↓ Skip to main content

The Stroke and Carer Optimal Health Program (SCOHP) to enhance psychosocial health: study protocol for a randomized controlled trial

Overview of attention for article published in Trials, September 2016
Altmetric Badge

Citations

dimensions_citation
11 Dimensions

Readers on

mendeley
197 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
The Stroke and Carer Optimal Health Program (SCOHP) to enhance psychosocial health: study protocol for a randomized controlled trial
Published in
Trials, September 2016
DOI 10.1186/s13063-016-1559-y
Pubmed ID
Authors

Catherine Brasier, Chantal F. Ski, David R. Thompson, Jan Cameron, Casey L. O’Brien, Nicola T. Lautenschlager, Graeme Gonzales, Ya-seng Arthur Hsueh, Gaye Moore, Simon R. Knowles, Susan L. Rossell, Rachel Haselden, David J. Castle

Abstract

Stroke is a leading cause of disability and distress, and often profoundly affects the quality of life of stroke survivors and their carers. With the support of carers, many stroke survivors are returning to live in the community despite the presence of disability and ongoing challenges. The sudden and catastrophic changes caused by stroke affects the mental, emotional and social health of both stroke survivors and carers. The aim of this study is to evaluate a Stroke and Carer Optimal Health Program (SCOHP) that adopts a person-centred approach and engages collaborative therapy to educate, support and improve the psychosocial health of stroke survivors and their carers. This study is a prospective randomised controlled trial. It will include a total of 168 stroke survivors and carers randomly allocated into an intervention group (SCOHP) or a control group (usual care). Participants randomised to the intervention group will receive nine (8 + 1 booster) sessions guided by a structured workbook. The primary outcome measures for stroke survivors and carers will be health-related quality of life (AQoL-6D and EQ-5D) and self-efficacy (GSE). Secondary outcome measures will include: anxiety and depression (HADS); coping (Brief COPE); work and social adjustment (WSAS); carer strain (MCSI); carer satisfaction (CASI); and treatment evaluation (TEI-SF and CEQ). Process evaluation and a health economic cost analysis will also be conducted. We believe that this is an innovative intervention that engages the stroke survivor and carer and will be significant in improving the psychosocial health, increasing independence and reducing treatment-related costs in this vulnerable patient-carer dyad. In addition, we expect that the intervention will assist carers and stroke survivors to negotiate the complexity of health services across the trajectory of care and provide practical skills to improve self-management. ACTRN12615001046594 . Registered on 7 October 2015.

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 197 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 197 100%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 22 11%
Student > Master 22 11%
Researcher 21 11%
Student > Bachelor 17 9%
Student > Doctoral Student 10 5%
Other 33 17%
Unknown 72 37%
Readers by discipline Count As %
Nursing and Health Professions 31 16%
Psychology 29 15%
Medicine and Dentistry 27 14%
Social Sciences 7 4%
Economics, Econometrics and Finance 4 2%
Other 20 10%
Unknown 79 40%